Perspectives From a Regional Plastic Surgery Centre on Evidence for the Purported Link Between SGLT2 Inhibitors and Fournier's Gangrene.

Taylor, Luke; Asmar, Omar; Mandal, Anirban; Tridente, Ascanio; Hardy, Kevin; Shokrollahi, Kayvan

Taylor, Luke; Asmar, Omar; Mandal, Anirban; Tridente, Ascanio; Hardy, Kevin; Shokrollahi, Kayvan.

Afiliação

Taylor L; Department of Upper Gastrointestinal Surgery, Royal Gwent Hospital, Newport, United Kingdom.
Asmar O; Mersey Regional Centre for Burns and Plastic Surgery, Whiston Hosiptal, Liverpool, United Kingdom.
Mandal A; Mersey Regional Centre for Burns and Plastic Surgery, Whiston Hosiptal, Liverpool, United Kingdom.
Tridente A; Department of Critical and Intensive Care, Whiston Hospital, Liverpool, United Kingdom.
Hardy K; Department of Diabetology and Endocrinology, Whiston Hospital, Liverpool, United Kingdom.
Shokrollahi K; Mersey Regional Centre for Burns and Plastic Surgery, Whiston Hosiptal, Liverpool, United Kingdom.

Front Surg ; 8: 754101, 2021.

Article em En | MEDLINE | ID: mdl-34957200

Palavras-chave

Fournier's Gangrene; SGLT2 inhibitors; burnspathology; plastic surgery; reconstructive surgery; surgery; type 2 diabetes (T2D)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Surg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google